JP2012524089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524089A5 JP2012524089A5 JP2012506078A JP2012506078A JP2012524089A5 JP 2012524089 A5 JP2012524089 A5 JP 2012524089A5 JP 2012506078 A JP2012506078 A JP 2012506078A JP 2012506078 A JP2012506078 A JP 2012506078A JP 2012524089 A5 JP2012524089 A5 JP 2012524089A5
- Authority
- JP
- Japan
- Prior art keywords
- leukemia
- mixed lineage
- mll
- use according
- translocated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000032839 leukemia Diseases 0.000 claims 30
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 10
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 9
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 9
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 8
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 8
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 8
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 5
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 5
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- -1 Dioxo-1H-pyrrol-3-yl Chemical group 0.000 claims 3
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 claims 3
- 208000036566 Erythroleukaemia Diseases 0.000 claims 3
- 208000021841 acute erythroid leukemia Diseases 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 1
- 229940049706 benzodiazepine Drugs 0.000 claims 1
- 150000001557 benzodiazepines Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16909409P | 2009-04-14 | 2009-04-14 | |
| US61/169,094 | 2009-04-14 | ||
| PCT/US2010/030315 WO2010120614A1 (en) | 2009-04-14 | 2010-04-08 | Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012524089A JP2012524089A (ja) | 2012-10-11 |
| JP2012524089A5 true JP2012524089A5 (OSRAM) | 2013-05-30 |
| JP5699129B2 JP5699129B2 (ja) | 2015-04-08 |
Family
ID=42174602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012506078A Expired - Fee Related JP5699129B2 (ja) | 2009-04-14 | 2010-04-08 | 造血器新生物および白血病の治療のためのベンゾジアゼピン誘導体 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8802668B2 (OSRAM) |
| EP (1) | EP2419106A1 (OSRAM) |
| JP (1) | JP5699129B2 (OSRAM) |
| KR (1) | KR101290509B1 (OSRAM) |
| CN (1) | CN102395372B (OSRAM) |
| AU (1) | AU2010236747B2 (OSRAM) |
| BR (1) | BRPI1013774A2 (OSRAM) |
| CA (1) | CA2758473C (OSRAM) |
| CL (1) | CL2011002531A1 (OSRAM) |
| DO (1) | DOP2011000312A (OSRAM) |
| EA (1) | EA018933B1 (OSRAM) |
| EC (1) | ECSP11011403A (OSRAM) |
| IL (1) | IL215107A0 (OSRAM) |
| MA (1) | MA33184B1 (OSRAM) |
| MX (1) | MX2011010937A (OSRAM) |
| MY (1) | MY157218A (OSRAM) |
| NZ (1) | NZ595413A (OSRAM) |
| PE (1) | PE20120772A1 (OSRAM) |
| SG (1) | SG175207A1 (OSRAM) |
| TN (1) | TN2011000500A1 (OSRAM) |
| TW (1) | TWI453022B (OSRAM) |
| UA (1) | UA103792C2 (OSRAM) |
| WO (1) | WO2010120614A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2758473C (en) * | 2009-04-14 | 2013-12-17 | Eli Lilly And Company | Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia |
| US9446048B2 (en) | 2011-03-17 | 2016-09-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins |
| US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| WO2014050779A1 (ja) * | 2012-09-25 | 2014-04-03 | 第一三共株式会社 | Ｇｓｋ３阻害剤と抗ｄｒ５抗体の組み合わせ |
| CN102887896B (zh) * | 2012-10-26 | 2015-11-18 | 南京工业大学 | 一种2-（咪唑并[1,2-a]吡啶-3-基）乙腈的制备方法 |
| CA2892927A1 (en) | 2012-12-10 | 2014-06-19 | Centogene Ag | Use of maleimide derivatives for preventing and treating leukemia |
| JP6534098B2 (ja) * | 2014-09-12 | 2019-06-26 | 国立大学法人 鹿児島大学 | 成人ｔ細胞白血病治療薬 |
| CN104945436B (zh) * | 2015-07-09 | 2017-02-08 | 山东罗欣药业集团股份有限公司 | 一种米诺膦酸的制备方法 |
| KR101694063B1 (ko) | 2015-10-12 | 2017-01-17 | 전남대학교병원 | Ｂｉｏ 화합물을 함유하는 심혈관질환의 치료용 조성물 |
| EP3534887B1 (en) | 2016-11-03 | 2023-09-20 | UCL Business Ltd | Cancer therapy for mixed lineage leukemia |
| WO2020163812A1 (en) | 2019-02-08 | 2020-08-13 | Frequency Therapeutics, Inc. | Valproic acid compounds and wnt agonists for treating ear disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| PT1483265E (pt) * | 2002-03-05 | 2007-01-31 | Lilly Co Eli | Derivados de purina como inibidores de quinase |
| TWI428132B (zh) * | 2007-07-02 | 2014-03-01 | Lilly Co Eli | 癌症化療效果之強化 |
| WO2009071620A1 (en) | 2007-12-05 | 2009-06-11 | Johannes Gutenberg-Universität Mainz | Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management |
| CA2758473C (en) | 2009-04-14 | 2013-12-17 | Eli Lilly And Company | Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia |
-
2010
- 2010-04-08 CA CA2758473A patent/CA2758473C/en not_active Expired - Fee Related
- 2010-04-08 AU AU2010236747A patent/AU2010236747B2/en not_active Ceased
- 2010-04-08 NZ NZ595413A patent/NZ595413A/xx not_active IP Right Cessation
- 2010-04-08 MY MYPI2011004899A patent/MY157218A/en unknown
- 2010-04-08 KR KR1020117024044A patent/KR101290509B1/ko not_active Expired - Fee Related
- 2010-04-08 PE PE2011001780A patent/PE20120772A1/es not_active Application Discontinuation
- 2010-04-08 BR BRPI1013774A patent/BRPI1013774A2/pt not_active IP Right Cessation
- 2010-04-08 SG SG2011074705A patent/SG175207A1/en unknown
- 2010-04-08 CN CN201080016621.9A patent/CN102395372B/zh not_active Expired - Fee Related
- 2010-04-08 EA EA201171243A patent/EA018933B1/ru not_active IP Right Cessation
- 2010-04-08 UA UAA201111273A patent/UA103792C2/uk unknown
- 2010-04-08 JP JP2012506078A patent/JP5699129B2/ja not_active Expired - Fee Related
- 2010-04-08 MX MX2011010937A patent/MX2011010937A/es active IP Right Grant
- 2010-04-08 WO PCT/US2010/030315 patent/WO2010120614A1/en not_active Ceased
- 2010-04-08 EP EP10714407A patent/EP2419106A1/en not_active Withdrawn
- 2010-04-08 US US12/756,213 patent/US8802668B2/en not_active Expired - Fee Related
- 2010-04-08 MA MA34234A patent/MA33184B1/fr unknown
- 2010-04-14 TW TW099111650A patent/TWI453022B/zh not_active IP Right Cessation
-
2011
- 2011-08-14 EC EC2011011403A patent/ECSP11011403A/es unknown
- 2011-09-12 IL IL215107A patent/IL215107A0/en unknown
- 2011-10-04 TN TNP2011000500A patent/TN2011000500A1/en unknown
- 2011-10-11 DO DO2011000312A patent/DOP2011000312A/es unknown
- 2011-10-12 CL CL2011002531A patent/CL2011002531A1/es unknown
-
2014
- 2014-04-30 US US14/265,844 patent/US9044487B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012524089A5 (OSRAM) | ||
| NZ595413A (en) | Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia | |
| CN102105152B (zh) | 包含cdks抑制剂和抗肿瘤剂的治疗组合 | |
| JP2010532364A5 (OSRAM) | ||
| JP2016539156A5 (OSRAM) | ||
| JP2012512158A5 (OSRAM) | ||
| IL201977A (en) | 6- (Pyrrolidine-3-Yl) -Pyrazolo [4,3- d] Pyrimidine-4-Ones, Pharmaceuticals Including Them and Their Use in the Preparation of Medicines to Treat Diseases | |
| FI3805222T3 (fi) | 7-bentsyyli-4-(2-metyylibentsyyli)-2,4,6,7,8,9-heksahydroimidatso[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-onijohdannaisia, niiden suoloja ja niiden käyttö hoidossa | |
| MX2019013643A (es) | Terapia de combinacion de 7-bencil-10-(2-metilbencil)-2,6,7,8,9,10 -hexahidroimidazo[1,2-a]pirido [4,3-d]pirimidin-5(3h)-ona. | |
| NZ592641A (en) | 3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine, its salts, and uses in medical treatment | |
| JP2015506348A5 (OSRAM) | ||
| JP2010529118A5 (OSRAM) | ||
| JP2010536849A5 (OSRAM) | ||
| FR2918986B1 (fr) | Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique | |
| JP2006504723A5 (OSRAM) | ||
| IL196243A (en) | [4,2,1] Triazole [3,4– a Pyridine Derivatives | |
| HK1208803A1 (en) | Crystalline forms of a bruton's tyrosine kinase inhibitor | |
| JP2012515184A5 (OSRAM) | ||
| IL196854A (en) | Indole compounds and their appropriate pharmaceutical salts and their use in the preparation of @ drugs | |
| IL215911A (en) | 7-aryl-1,2,4-triazolo [3,4- a] derivatives, pharmaceutical preparations containing them and methods of preparation and uses thereof | |
| IL195821A (en) | Derivatives 5 (6h), 7- Dioxo-6- (4-Methylphiprazine-1-Il) -11,10,9,8,7,5-Hexhydrocyclopent [g] phenyl / pyrido [b [pyrrolo [4,3- e] Andol, pharmaceutical preparations containing them and their use in the preparation of medicines | |
| IL289164A (en) | The history of imidazo[2,1-a)pyridinyl and their use in the treatment of diseases | |
| RU2009127351A (ru) | Комбинации антифолатного агента в лечении рака | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2013518124A5 (OSRAM) |